Botox and Dysport are both botulinum toxin type A products used in medical and aesthetic treatment.
Although often discussed together, they are not identical products and differ in several important ways, including:
- formulation
- dosing units
- manufacturing processes
- diffusion characteristics
- accessory proteins
- clinical behaviour
Both products are widely used internationally across therapeutic and aesthetic settings.
Are Botox and Dysport the Same Thing?
No.
Both products contain botulinum toxin type A, but they are produced differently and are not directly interchangeable on a unit-for-unit basis.
This is important because:
- dosing differs between products
- clinical effects may vary
- injection planning differs
- research comparisons can be complex
Brand Names and Manufacturers
Botox
Botox is manufactured by Allergan (AbbVie).
Dysport
Dysport is manufactured by Ipsen.
Both products have established medical and aesthetic indications in multiple countries.
Differences in Dosing Units
One of the most important distinctions is that Botox and Dysport use different biological activity units.
As a result:
- 1 unit of Botox does not equal 1 unit of Dysport
- direct numerical comparison can be misleading
- conversion ratios remain an area of discussion and clinical variation
Treatment planning should therefore always consider the specific product being used.
Diffusion and Spread
There has been ongoing discussion regarding whether Botox and Dysport differ in:
- diffusion characteristics
- tissue spread
- onset
- duration
- clinical behaviour
Interpretation of this research remains complex.
Multiple factors may influence spread, including:
- injection technique
- dilution
- dose
- anatomy
- treatment area
- muscle activity
Public discussion of diffusion is often oversimplified.
Accessory Proteins and Formulation
Different botulinum toxin products vary in:
- protein composition
- manufacturing methods
- stabilising components
- molecular characteristics
Research continues into whether such differences influence:
- immunogenicity
- resistance
- duration
- clinical performance
This remains an active area of scientific investigation.
Medical and Aesthetic Use
Both Botox and Dysport are used across:
- chronic migraine
- dystonia
- hyperhidrosis
- spasticity
- facial lines
- masseter treatment
- periocular treatment
Choice of product depends on multiple factors including:
- clinical indication
- practitioner experience
- anatomical considerations
- dosing preference
- patient response
Is One Better Than The Other?
There is no universal answer.
Different clinicians may have different preferences depending on:
- treatment goals
- injection technique
- patient anatomy
- onset preference
- prior response
- clinical experience
Scientific comparison between products remains complex and sometimes controversial.
Why Product Comparison Matters
As public awareness of BTX treatments continues to grow, product terminology and marketing claims can become confusing.
Understanding that different botulinum toxin products are related but not identical is important for:
- informed discussion
- realistic expectations
- treatment interpretation
- scientific understanding
Frequently Asked Questions
Are Botox and Dysport both botulinum toxin?
Yes. Both are botulinum toxin type A products.
Can Botox and Dysport doses be directly compared?
No. Their dosing units are not directly interchangeable.
Does Dysport spread more than Botox?
Research and clinical discussion continue regarding differences in spread and diffusion characteristics.
Are both used medically and aesthetically?
Yes. Both products are used across multiple medical and aesthetic indications.
Is one product safer than the other?
Safety depends on multiple factors including treatment planning, dosing, anatomy and clinical context.
Medical Disclaimer
The information provided on BTXExpert is intended for educational purposes only and should not be considered medical advice. Individuals should seek personalised advice from an appropriately qualified healthcare professional regarding diagnosis, treatment suitability, risks and alternatives.